Salarius Pharmaceuticals's total assets for Q were $3.86M, an increase of 8.59% from the previous quarter. SLRX total liabilities were $934.58K for the fiscal quarter, a -20.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.